First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
作者:
主题词
腺病毒科(Adenoviridae);青少年(Adolescent);成年人(Adult);动物(Animals);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);人类(Humans);白细胞, 单核(Leukocytes, Mononuclear);中年人(Middle Aged);核壳(Nucleocapsid);黑猩猩属(Pan troglodytes);呼吸道合胞体病毒感染(Respiratory Syncytial Virus Infections);呼吸道合胞病毒疫苗(Respiratory Syncytial Virus Vaccines);病毒蛋白质类(Viral Proteins);病毒粒子(Virion);青年人(Young Adult)
DOI
10.1093/cid/ciz653
PMID
31340042
发布时间
2022-02-16
- 浏览8

Clinical infectious diseases
2073-2081页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文